NanoViricides Inc is UNDERVALUED at 6.17 per share with modest projections ahead. NanoViricides NEW has Sharpe Ratio of -0.0364, which conveys that the firm had -0.0364% of return per unit of risk over the last month. Macroaxis standpoint towards estimating the risk of any stock is to look at both systematic and unsystematic factors of the business, including all available market data and technical indicators. NanoViricides Inc exposes twenty-eight different technical indicators, which can help you to evaluate volatility that cannot be diversified away. Please be advised to verify NanoViricides Inc NEW risk adjusted performance of (0.06), and Mean Deviation of 5.39 to check out the risk estimate we provide.